In 2012, the FDA approved a new drug for weight loss – Belviq. This drug is used as an obesity therapy in adult patients, whose BMI is:
30 kg / m2 or more
27 kg / m2 and above, in case of risk factors such as type 2 diabetes, hypertension, dyslipidemia)